PetMed Express Inc (PETS) - Total Liabilities

Latest as of December 2025: $55.20 Million USD

Based on the latest financial reports, PetMed Express Inc (PETS) has total liabilities worth $55.20 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PetMed Express Inc (PETS) cash conversion ratio to assess how effectively this company generates cash.

PetMed Express Inc - Total Liabilities Trend (2000–2026)

This chart illustrates how PetMed Express Inc's total liabilities have evolved over time, based on quarterly financial data. Check PETS financial resilience to evaluate the company's liquid asset resilience ratio.

PetMed Express Inc Competitors by Total Liabilities

The table below lists competitors of PetMed Express Inc ranked by their total liabilities.

Company Country Total Liabilities
Broendbyernes IF Fodbold AS
CO:BIF
Denmark Dkr244.49 Million
Thonburi Medical Centre Public Company Limited
BK:KDH
Thailand ฿197.58 Million
Fonet Bilgi Teknolojileri AS
IS:FONET
Turkey TL434.59 Million
Samebest Co Ltd
TWO:8489
Taiwan NT$1.08 Billion
Aether Holdings, Inc.
NASDAQ:ATHR
USA $637.09K
Sinil Pharmaceutical Co. Ltd
KQ:012790
Korea ₩18.23 Billion
Ege Seramik Sanayi ve Ticaret AS
IS:EGSER
Turkey TL4.75 Billion
Mildex Optical
TWO:4729
Taiwan NT$1.76 Billion

Liability Composition Analysis (2000–2026)

This chart breaks down PetMed Express Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is PetMed Express Inc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.89 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.68 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.63 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PetMed Express Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PetMed Express Inc (2000–2026)

The table below shows the annual total liabilities of PetMed Express Inc from 2000 to 2026.

Year Total Liabilities Change
2026-03-31 $63.57 Million -13.11%
2024-03-31 $73.15 Million +21.84%
2023-03-31 $60.04 Million +75.90%
2022-03-31 $34.13 Million -26.14%
2021-03-31 $46.22 Million +82.58%
2020-03-31 $25.31 Million +28.19%
2019-03-31 $19.75 Million +3.36%
2018-03-31 $19.11 Million -1.74%
2017-03-31 $19.44 Million +174.46%
2016-03-31 $7.08 Million -4.49%
2015-03-31 $7.42 Million -9.08%
2014-03-31 $8.16 Million -10.99%
2013-03-31 $9.16 Million -7.27%
2012-03-31 $9.88 Million +6.47%
2011-03-31 $9.28 Million +26.92%
2010-03-31 $7.31 Million +4.55%
2009-03-31 $6.99 Million +8.94%
2008-03-31 $6.42 Million -12.70%
2007-03-31 $7.35 Million +47.55%
2006-03-31 $4.98 Million +27.73%
2005-03-31 $3.90 Million -13.01%
2004-03-31 $4.49 Million +30.68%
2003-03-31 $3.43 Million +11.77%
2002-03-31 $3.07 Million -18.04%
2001-03-31 $3.75 Million -20.19%
2000-03-31 $4.70 Million --

About PetMed Express Inc

NASDAQ:PETS USA Pharmaceutical Retailers
Market Cap
$49.22 Million
Market Cap Rank
#21942 Global
#4650 in USA
Share Price
$2.30
Change (1 day)
+2.68%
52-Week Range
$1.60 - $4.19
All Time High
$44.49
About

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more